25H-NB:
493,
494 ·
837,
838,
839
Braden, MR. Towards a biophysical understanding of hallucinogen action Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2007. 8.4 MB. #25H-NB
Braden, MR; Parrish, JC; Naylor, JC; Nichols, DE. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists Mol. Pharmacol., 1 Jan 2006, 70 (6), 1956–1964. 361 kB. https://doi.org/10.1124/mol.106.028720 #25H-NB
Halberstadt, AL. Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens In Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 18 Jan 2017; pp 283-311. 826 kB. https://doi.org/10.1007/7854_2016_64
24-NB · 24H-NB · N-Benzyl-2,4-dimethoxyphenethylamine
2,5-Dimethoxy-4-(2-methylphenyl)phenethylamine · 2C-BI-3
4-PhEtO-2-MPEA · 4-Phenethyloxy-2-methoxyphenethylamine
5-PhEtO-2-MPEA · 5-Phenethyloxy-2-methoxyphenethylamine
4-Benzyloxy-3-methoxyamphetamine · BZOMA
2-Benzyloxy-5-methoxyamphetamine · 2-BnO-5-MA
2-MPEA-NBOMe · N-(2-Methoxybenzyl)-2-methoxyphenethylamine
2C-BN · 4-Benzyl-2,5-dimethoxyphenethylamine
3-MeO-NBOMe · 3-MeO-PEA-NBOMe